Selected research
Industry Research
Budesonide Sprays Industry Research Report 2026
Market perspective
The global Budesonide Sprays market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Budesonide Sprays is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Budesonide Sprays is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Budesonide Sprays is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Budesonide Sprays include Abbott, Takeda, Teva, Sandoz, Novartis, Mylan, Pfizer, AstraZeneca and Wellcome Australia Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Budesonide Sprays market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Budesonide Sprays Market by Company
Abbott
Takeda
Teva
Sandoz
Novartis
Mylan
Pfizer
AstraZeneca
Wellcome Australia Ltd
Synmosa Biopharma Corporation
Squibb
Skyepharma
Shimadzu Corp
Shanghai Sine Pharmaceutical
Manus Aktteva Biopharma LLP
Lunan Better Pharmaceutical
Cipla
Chiesi Farmaceutici S.p.A
Boehringer Ingelheim
Allgen Pharmaceuticals
Budesonide Sprays Segment by Type
32ug*120 Spray
64ug*120 Spray
Other
Budesonide Sprays Segment by Application
Hospitals
Clinics
Other
Budesonide Sprays Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Budesonide Sprays market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Budesonide Sprays and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Budesonide Sprays.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Budesonide Sprays manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Budesonide Sprays by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Budesonide Sprays in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 32ug*120 Spray
- 64ug*120 Spray
- Other
Applications
- Hospitals
- Clinics
- Other
Companies covered
- Abbott
- Takeda
- Teva
- Sandoz
- Novartis
- Mylan
- Pfizer
- AstraZeneca
- Wellcome Australia Ltd
- Synmosa Biopharma Corporation
- Squibb
- Skyepharma
- Shimadzu Corp
- Shanghai Sine Pharmaceutical
- Manus Aktteva Biopharma LLP
- Lunan Better Pharmaceutical
- Cipla
- Chiesi Farmaceutici S.p.A
- Boehringer Ingelheim
- Allgen Pharmaceuticals
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Budesonide Sprays Market Size (2021-2032)
- 2.2.2 Global Budesonide Sprays Sales (2021-2032)
- 2.2.3 Global Budesonide Sprays Market Average Price (2021-2032)
- 2.3 Budesonide Sprays by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 32ug*120 Spray
- 2.3.3 64ug*120 Spray
- 2.3.4 Other
- 2.4 Budesonide Sprays by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospitals
- 2.4.3 Clinics
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Budesonide Sprays Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Budesonide Sprays Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Budesonide Sprays Revenue of Manufacturers (2021-2026)
- 3.4 Global Budesonide Sprays Average Price by Manufacturers (2021-2026)
- 3.5 Global Budesonide Sprays Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Budesonide Sprays, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Budesonide Sprays, Product Type & Application
- 3.8 Global Manufacturers of Budesonide Sprays, Established Date
- 3.9 Global Budesonide Sprays Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Abbott
- 4.1.1 Abbott Company Information
- 4.1.2 Abbott Business Overview
- 4.1.3 Abbott Budesonide Sprays Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Abbott Budesonide Sprays Product Portfolio
- 4.1.5 Abbott Recent Developments
- 4.2 Takeda
- 4.2.1 Takeda Company Information
- 4.2.2 Takeda Business Overview
- 4.2.3 Takeda Budesonide Sprays Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Takeda Budesonide Sprays Product Portfolio
- 4.2.5 Takeda Recent Developments
- 4.3 Teva
- 4.3.1 Teva Company Information
- 4.3.2 Teva Business Overview
- 4.3.3 Teva Budesonide Sprays Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Teva Budesonide Sprays Product Portfolio
- 4.3.5 Teva Recent Developments
- 4.4 Sandoz
- 4.4.1 Sandoz Company Information
- 4.4.2 Sandoz Business Overview
- 4.4.3 Sandoz Budesonide Sprays Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Sandoz Budesonide Sprays Product Portfolio
- 4.4.5 Sandoz Recent Developments
- 4.5 Novartis
- 4.5.1 Novartis Company Information
- 4.5.2 Novartis Business Overview
- 4.5.3 Novartis Budesonide Sprays Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Novartis Budesonide Sprays Product Portfolio
- 4.5.5 Novartis Recent Developments
- 4.6 Mylan
- 4.6.1 Mylan Company Information
- 4.6.2 Mylan Business Overview
- 4.6.3 Mylan Budesonide Sprays Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Mylan Budesonide Sprays Product Portfolio
- 4.6.5 Mylan Recent Developments
- 4.7 Pfizer
- 4.7.1 Pfizer Company Information
- 4.7.2 Pfizer Business Overview
- 4.7.3 Pfizer Budesonide Sprays Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Pfizer Budesonide Sprays Product Portfolio
- 4.7.5 Pfizer Recent Developments
- 4.8 AstraZeneca
- 4.8.1 AstraZeneca Company Information
- 4.8.2 AstraZeneca Business Overview
- 4.8.3 AstraZeneca Budesonide Sprays Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 AstraZeneca Budesonide Sprays Product Portfolio
- 4.8.5 AstraZeneca Recent Developments
- 4.9 Wellcome Australia Ltd
- 4.9.1 Wellcome Australia Ltd Company Information
- 4.9.2 Wellcome Australia Ltd Business Overview
- 4.9.3 Wellcome Australia Ltd Budesonide Sprays Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Wellcome Australia Ltd Budesonide Sprays Product Portfolio
- 4.9.5 Wellcome Australia Ltd Recent Developments
- 4.10 Synmosa Biopharma Corporation
- 4.10.1 Synmosa Biopharma Corporation Company Information
- 4.10.2 Synmosa Biopharma Corporation Business Overview
- 4.10.3 Synmosa Biopharma Corporation Budesonide Sprays Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Synmosa Biopharma Corporation Budesonide Sprays Product Portfolio
- 4.10.5 Synmosa Biopharma Corporation Recent Developments
- 4.11 Squibb
- 4.11.1 Squibb Company Information
- 4.11.2 Squibb Business Overview
- 4.11.3 Squibb Budesonide Sprays Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Squibb Budesonide Sprays Product Portfolio
- 4.11.5 Squibb Recent Developments
- 4.12 Skyepharma
- 4.12.1 Skyepharma Company Information
- 4.12.2 Skyepharma Business Overview
- 4.12.3 Skyepharma Budesonide Sprays Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Skyepharma Budesonide Sprays Product Portfolio
- 4.12.5 Skyepharma Recent Developments
- 4.13 Shimadzu Corp
- 4.13.1 Shimadzu Corp Company Information
- 4.13.2 Shimadzu Corp Business Overview
- 4.13.3 Shimadzu Corp Budesonide Sprays Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Shimadzu Corp Budesonide Sprays Product Portfolio
- 4.13.5 Shimadzu Corp Recent Developments
- 4.14 Shanghai Sine Pharmaceutical
- 4.14.1 Shanghai Sine Pharmaceutical Company Information
- 4.14.2 Shanghai Sine Pharmaceutical Business Overview
- 4.14.3 Shanghai Sine Pharmaceutical Budesonide Sprays Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Shanghai Sine Pharmaceutical Budesonide Sprays Product Portfolio
- 4.14.5 Shanghai Sine Pharmaceutical Recent Developments
- 4.15 Manus Aktteva Biopharma LLP
- 4.15.1 Manus Aktteva Biopharma LLP Company Information
- 4.15.2 Manus Aktteva Biopharma LLP Business Overview
- 4.15.3 Manus Aktteva Biopharma LLP Budesonide Sprays Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Manus Aktteva Biopharma LLP Budesonide Sprays Product Portfolio
- 4.15.5 Manus Aktteva Biopharma LLP Recent Developments
- 4.16 Lunan Better Pharmaceutical
- 4.16.1 Lunan Better Pharmaceutical Company Information
- 4.16.2 Lunan Better Pharmaceutical Business Overview
- 4.16.3 Lunan Better Pharmaceutical Budesonide Sprays Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Lunan Better Pharmaceutical Budesonide Sprays Product Portfolio
- 4.16.5 Lunan Better Pharmaceutical Recent Developments
- 4.17 Cipla
- 4.17.1 Cipla Company Information
- 4.17.2 Cipla Business Overview
- 4.17.3 Cipla Budesonide Sprays Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Cipla Budesonide Sprays Product Portfolio
- 4.17.5 Cipla Recent Developments
- 4.18 Chiesi Farmaceutici S.p.A
- 4.18.1 Chiesi Farmaceutici S.p.A Company Information
- 4.18.2 Chiesi Farmaceutici S.p.A Business Overview
- 4.18.3 Chiesi Farmaceutici S.p.A Budesonide Sprays Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 Chiesi Farmaceutici S.p.A Budesonide Sprays Product Portfolio
- 4.18.5 Chiesi Farmaceutici S.p.A Recent Developments
- 4.19 Boehringer Ingelheim
- 4.19.1 Boehringer Ingelheim Company Information
- 4.19.2 Boehringer Ingelheim Business Overview
- 4.19.3 Boehringer Ingelheim Budesonide Sprays Sales, Revenue and Gross Margin (2021-2026)
- 4.19.4 Boehringer Ingelheim Budesonide Sprays Product Portfolio
- 4.19.5 Boehringer Ingelheim Recent Developments
- 4.20 Allgen Pharmaceuticals
- 4.20.1 Allgen Pharmaceuticals Company Information
- 4.20.2 Allgen Pharmaceuticals Business Overview
- 4.20.3 Allgen Pharmaceuticals Budesonide Sprays Sales, Revenue and Gross Margin (2021-2026)
- 4.20.4 Allgen Pharmaceuticals Budesonide Sprays Product Portfolio
- 4.20.5 Allgen Pharmaceuticals Recent Developments
5 Global Budesonide Sprays Market Scenario by Region
- 5.1 Global Budesonide Sprays Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Budesonide Sprays Sales by Region: 2021-2032
- 5.2.1 Global Budesonide Sprays Sales by Region: 2021-2026
- 5.2.2 Global Budesonide Sprays Sales by Region: 2027-2032
- 5.3 Global Budesonide Sprays Revenue by Region: 2021-2032
- 5.3.1 Global Budesonide Sprays Revenue by Region: 2021-2026
- 5.3.2 Global Budesonide Sprays Revenue by Region: 2027-2032
- 5.4 North America Budesonide Sprays Market Facts & Figures by Country
- 5.4.1 North America Budesonide Sprays Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Budesonide Sprays Sales by Country (2021-2032)
- 5.4.3 North America Budesonide Sprays Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Budesonide Sprays Market Facts & Figures by Country
- 5.5.1 Europe Budesonide Sprays Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Budesonide Sprays Sales by Country (2021-2032)
- 5.5.3 Europe Budesonide Sprays Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Budesonide Sprays Market Facts & Figures by Country
- 5.6.1 Asia Pacific Budesonide Sprays Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Budesonide Sprays Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Budesonide Sprays Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Budesonide Sprays Market Facts & Figures by Country
- 5.7.1 South America Budesonide Sprays Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Budesonide Sprays Sales by Country (2021-2032)
- 5.7.3 South America Budesonide Sprays Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Budesonide Sprays Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Budesonide Sprays Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Budesonide Sprays Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Budesonide Sprays Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Budesonide Sprays Sales by Type (2021-2032)
- 6.1.1 Global Budesonide Sprays Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Budesonide Sprays Sales Market Share by Type (2021-2032)
- 6.2 Global Budesonide Sprays Revenue by Type (2021-2032)
- 6.2.1 Global Budesonide Sprays Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Budesonide Sprays Revenue Market Share by Type (2021-2032)
- 6.3 Global Budesonide Sprays Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Budesonide Sprays Sales by Application (2021-2032)
- 7.1.1 Global Budesonide Sprays Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Budesonide Sprays Sales Market Share by Application (2021-2032)
- 7.2 Global Budesonide Sprays Revenue by Application (2021-2032)
- 7.2.1 Global Budesonide Sprays Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Budesonide Sprays Revenue Market Share by Application (2021-2032)
- 7.3 Global Budesonide Sprays Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Budesonide Sprays Value Chain Analysis
- 8.1.1 Budesonide Sprays Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Budesonide Sprays Production Mode & Process
- 8.2 Budesonide Sprays Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Budesonide Sprays Distributors
- 8.2.3 Budesonide Sprays Customers
9 Global Budesonide Sprays Analyzing Market Dynamics
- 9.1 Budesonide Sprays Industry Trends
- 9.2 Budesonide Sprays Industry Drivers
- 9.3 Budesonide Sprays Industry Opportunities and Challenges
- 9.4 Budesonide Sprays Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst